Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus

被引:3
|
作者
Cressey, Tim R. [1 ,2 ,3 ]
Harrison, Linda [4 ]
Achalapong, Jullapong [5 ]
Kanjanavikai, Prateep [6 ]
Ayudhaya, Orada Patamasingh Na [7 ]
Liampongsabuddhi, Prateung [8 ]
Siriwachirachai, Thitiporn [9 ]
Putiyanun, Chaiwat [10 ]
Suriyachai, Pornnapa
Tierney, Camlin [4 ]
Salvadori, Nicolas [1 ]
Chinwong, Dujrudee [11 ]
Decker, Luc [12 ]
Tawon, Yardpiroon [1 ]
Murphy, Trudy V. [13 ]
Ngo-Giang-Huong, Nicole [1 ,2 ,12 ]
Siberry, George K. [14 ]
Jourdain, Gonzague [1 ,2 ,11 ]
机构
[1] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, PHPT IRD, Chiang Mai, Thailand
[2] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[3] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England
[4] Harvard TH Chan Sch Publ Hlth, CBAR, Boston, MA USA
[5] Chiangrai Prachanukroh Hosp, Chiang Rai, Thailand
[6] Banglamung Hosp, Chon Buri, Thailand
[7] Nopparat Rajathanee Hosp, Bangkok, Thailand
[8] Lampang Hosp, Lampang, Thailand
[9] Khon Kaen Hosp, Khon Kaen, Thailand
[10] Chiang Kham Hosp, Phayao, Thailand
[11] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Care, Chiang Mai, Thailand
[12] IRD, Unite Mixte Int PHPT 174, Chiang Mai, Thailand
[13] Ctr Dis Control & Prevent, Atlanta, GA USA
[14] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA
关键词
pregnancy; tenofovir; hepatitis B virus; pharmacokinetics; CLINICAL-PHARMACOLOGY; PHARMACOKINETICS; HIV;
D O I
10.1128/AAC.01686-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We assessed tenofovir exposure during pregnancy and postpartum in hepatitis B virus (HBV)-infected HIV-uninfected women receiving tenofovir disoproxil fumarate (TDF) to prevent mother-to-child transmission of HBV. Data from 154 women who received TDF within a randomized controlled trial were included. Individual plasma tenofovir exposures (area under the concentration-time curve from 0 to 24 h [AUC0-24]) were estimated using a population pharmacokinetic approach. The estimated geometric mean tenofovir AUC(0-24) was 20% (95% confidence interval [95% CI], 19 to 21%) lower during pregnancy than during postpartum; this modest reduction in the absence of HBV transmission suggests that no dose adjustment is needed.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Editorial: tenofovir disoproxil fumarate and prevention of mother-to-child transmission of hepatitis B virus
    Han, Zhenyan
    Hou, Hongying
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (06) : 707 - 708
  • [2] Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus
    Fan, Li-Wei
    Zhao, Chang
    Ma, Yi-Long
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (04) : 475 - 476
  • [3] Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus
    Liegeon, Geoffroy
    Ngo-Giang-Huong, Nicole
    Salvadori, Nicolas
    Bunpo, Piyawan
    Cressey, Ratchada
    Achalapong, Jullapong
    Kanjanavikai, Prateep
    Ayudhaya, Orada Patamasingh Na
    Prommas, Sinart
    Siriwachirachai, Thitiporn
    Sabsanong, Prapan
    Mary, Jean Yves
    Jourdain, Gonzague
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (04) : 1111 - 1118
  • [4] Editorial: tenofovir disoproxil fumarate and prevention of mother-to-child transmission of hepatitis B virus-authors' reply
    Chang, Kai-Chi
    Chang, Mei-Hwei
    Lin, Lung-Huang
    Chen, Huey-Ling
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (06) : 708 - 709
  • [5] THE EFFICACY AND SAFETY OF TELBIVUDINE OR TENOFOVIR DISOPROXIL IN PREGNANCY FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS
    Huang, H.
    Zhang, Y.
    Wu, Q.
    Wang, Y.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S560 - S560
  • [6] The Efficacy And Safety Of Telbivudine And/Or Tenofovir Disoproxil In Pregnancy For Prevention Of Mother-To-Child Transmission Of Hepatitis B Virus
    Zhang, Yanqiong
    Huang, Hongfei
    Wu, Quanxin
    Wang, Yuming
    [J]. HEPATOLOGY, 2015, 62 : 1195A - 1195A
  • [7] Tenofovir Disoproxil: Effective and Safe in Prevention of Mother-to-child Transmission of Hepatitis B Virus
    Huang, Hongfei
    Wu, Quanxin
    Wang, Yuming
    [J]. HEPATOLOGY, 2014, 60 : 1088A - 1088A
  • [8] Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
    Baciu, Iulia
    Domuncu, Dalila-Ana
    Domuncu, Tiberiu
    Ciobanu, Anca Marina
    Voiosu, Theodor
    Peltecu, Gheorghe
    Panaitescu, Anca Maria
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2021, 48 (01): : 9 - 18
  • [9] Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus. Authors' reply
    Pan, Calvin Q.
    Zhang, Hua
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (04) : 477 - 478
  • [10] Critical Insights Into the Effectiveness and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Preventing Mother-to-Child Transmission of Hepatitis B Virus
    Hao, Lu
    Xue, Jisu
    [J]. CLINICAL INFECTIOUS DISEASES, 2024,